| 摘要 |
The present invention provides methods for providing a prognosis for lung cancer using a panel of eleven molecular markers that includes BAG1, BRCA1, CDC6, CDK2AP1, ERBB3, FUT3, IL11, LCK, RND3, SH3BGR, and WNT3A, which are differentially expressed in lung cancer. The eleven markers are related to patient prognosis to 5-year overall survival outcomes, and are particularly useful in providing a prognosis for non-squamous NSCLC. |
| 申请人 |
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA;PINPOINT GENOMICS, INC. |
发明人 |
MANN, MICHAEL, J.;JABLONS, DAVID, M.;KRATZ, JOHANNES;BERRYMAN, DAVID |
